BUZZ-Oncolytics Biotech Inc: Orphan status for pancreatic cancer drug

Tue Feb 17, 2015 9:08am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drug developer's shares up 25.4 pct at 65 cents premarket

** FDA grants orphan drug designation for company's pancreatic cancer drug candidate

** Drug already received status for ovarian cancer

** Orphan drug status granted to drugs developed to treat rare diseases; gives drug developer incentives, including 7-year marketing exclusivity

** Up to Friday's close, stock had fallen more than 68 percent in past 12 months